Cardiovascular safety of romosozumab:​ new insights from postmenopausal women with chronic kidney disease

wbldb

Cardiovascular safety of romosozumab: new insights from postmenopausal women with chronic kidney disease

J Bone Miner Res. February 2023;38(2):354-355

Cited Works (2)

Year	Entry
2022	Miller PD, Adachi JD, Albergaria B-H, Cheung AM, Chines AA, Gielen E, Langdahl BL, Miyauchi A, Oates M, Reid IR, Santiago NR, Vanderkelen M, Wang Z, Yu Z. Efficacy and safety of romosozumab among postmenopausal women with osteoporosis and mild-to-moderate chronic kidney disease. J Bone Miner Res. August 2022;37(8):1437-1445.
2022	Oda T, Jödicke AM, Robinson DE, Delmestri A, Keogh RH, Prieto-Alhambra D. Oral bisphosphonates are associated with increased risk of severe acute kidney injury in elderly patients with complex health needs: a self-controlled case series in the United Kingdom. J Bone Miner Res. July 2022;37(7):1270-1278.